Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065321211> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2065321211 endingPage "496" @default.
- W2065321211 startingPage "493" @default.
- W2065321211 abstract "Atomic absorption spectrophotometric method, for determination of arsenic and iron concentration in finger and foot muscles from Blackfoot Dim Patients(BFDPs), by amputation were developed. Thirty-four cases of BFDPs, at the most strict clinical examination and thirty cases of Non-BFDPs(NBFDPs) from the traffic accidents. NBFDPs from the same district were compared as the controls. Arsenic has been claimed to be major causative agents of Blackfoot Disease(BFD) in the south-western coast of Taiwan. We published several papers on this and presented a conception that, as with the increase in linical stages from the zero, first, second, third and fourth, the increase in the arsenic concentration in blood, hair and urine accompanies as the BFD progressed, although at the third and fourth stages, arsenic decrease might be induced by the antagonistic effect of selenium, zinc and iron. For the purpose to prove this, the study was carried out to check whether at the fourth stage, the concentration of arsenic in BFDPs finger and foot muscles by amputation are higher than that of NBFDPs and whether it is also the case with the blood of BFDPs . The arsenic in muscles of finger and foot of BFDPs by amputation was more than 10times higher than the NBFDPs at the raze of 0.80±0.57μg/g>0.07±0.05μg/g and they were also about 8times higher than the blood of BFDPs at the fourth clinical stages at the rate of 0.80±0.57μg/g>0.091±0.052μg/ml. Both of them had significantly difference with P<0.01. These evidences directly indicated that arsenic might be a major causative agent of BFD.supplementThe iron in muscles of finger and foot of BFDPs by amputation were also about 2times higher than that of NBFDPs at the rate of 39.63±23.54μg/g>19.82±7.61μg/g and had a significance difference with P<0.05. These results were on the contraiy to the blood, when compared with the blood iron concentration in BFDPs at fourth stage and NBFDPs. The NBFDPs were higher than the BFDPs at the rate of 553.28±92.96μg/ml> 510.71±163.52μg/ml. Therefore iron may have some antagonistic effect to arsenic toxicity for the BFDPs and this fact is worthy of more academic study of the BFD in clinical application." @default.
- W2065321211 created "2016-06-24" @default.
- W2065321211 creator A5006915245 @default.
- W2065321211 creator A5056092882 @default.
- W2065321211 creator A5059555856 @default.
- W2065321211 creator A5081963362 @default.
- W2065321211 creator A5091565640 @default.
- W2065321211 creator A5091809365 @default.
- W2065321211 date "1997-01-01" @default.
- W2065321211 modified "2023-09-25" @default.
- W2065321211 title "Arsenic and Iron in the Finger and Foot Muscle from Blackfoot Disease Patients." @default.
- W2065321211 cites W610264985 @default.
- W2065321211 doi "https://doi.org/10.2116/analsci.13.supplement_493" @default.
- W2065321211 hasPublicationYear "1997" @default.
- W2065321211 type Work @default.
- W2065321211 sameAs 2065321211 @default.
- W2065321211 citedByCount "3" @default.
- W2065321211 crossrefType "journal-article" @default.
- W2065321211 hasAuthorship W2065321211A5006915245 @default.
- W2065321211 hasAuthorship W2065321211A5056092882 @default.
- W2065321211 hasAuthorship W2065321211A5059555856 @default.
- W2065321211 hasAuthorship W2065321211A5081963362 @default.
- W2065321211 hasAuthorship W2065321211A5091565640 @default.
- W2065321211 hasAuthorship W2065321211A5091809365 @default.
- W2065321211 hasBestOaLocation W20653212111 @default.
- W2065321211 hasConcept C115076146 @default.
- W2065321211 hasConcept C138885662 @default.
- W2065321211 hasConcept C141071460 @default.
- W2065321211 hasConcept C178790620 @default.
- W2065321211 hasConcept C185592680 @default.
- W2065321211 hasConcept C2776204877 @default.
- W2065321211 hasConcept C2780026642 @default.
- W2065321211 hasConcept C41895202 @default.
- W2065321211 hasConcept C42407357 @default.
- W2065321211 hasConcept C502230775 @default.
- W2065321211 hasConcept C553756173 @default.
- W2065321211 hasConcept C55493867 @default.
- W2065321211 hasConcept C71924100 @default.
- W2065321211 hasConceptScore W2065321211C115076146 @default.
- W2065321211 hasConceptScore W2065321211C138885662 @default.
- W2065321211 hasConceptScore W2065321211C141071460 @default.
- W2065321211 hasConceptScore W2065321211C178790620 @default.
- W2065321211 hasConceptScore W2065321211C185592680 @default.
- W2065321211 hasConceptScore W2065321211C2776204877 @default.
- W2065321211 hasConceptScore W2065321211C2780026642 @default.
- W2065321211 hasConceptScore W2065321211C41895202 @default.
- W2065321211 hasConceptScore W2065321211C42407357 @default.
- W2065321211 hasConceptScore W2065321211C502230775 @default.
- W2065321211 hasConceptScore W2065321211C553756173 @default.
- W2065321211 hasConceptScore W2065321211C55493867 @default.
- W2065321211 hasConceptScore W2065321211C71924100 @default.
- W2065321211 hasIssue "Supplement" @default.
- W2065321211 hasLocation W20653212111 @default.
- W2065321211 hasOpenAccess W2065321211 @default.
- W2065321211 hasPrimaryLocation W20653212111 @default.
- W2065321211 hasRelatedWork W2002457384 @default.
- W2065321211 hasRelatedWork W2031970319 @default.
- W2065321211 hasRelatedWork W2038511792 @default.
- W2065321211 hasRelatedWork W2052127933 @default.
- W2065321211 hasRelatedWork W2068170531 @default.
- W2065321211 hasRelatedWork W2074314324 @default.
- W2065321211 hasRelatedWork W2075600307 @default.
- W2065321211 hasRelatedWork W2165895362 @default.
- W2065321211 hasRelatedWork W2378754651 @default.
- W2065321211 hasRelatedWork W2438943592 @default.
- W2065321211 hasVolume "13" @default.
- W2065321211 isParatext "false" @default.
- W2065321211 isRetracted "false" @default.
- W2065321211 magId "2065321211" @default.
- W2065321211 workType "article" @default.